Novartis’ Ultibro Breezhaler reduces lung hyperinflation in COPD patients

23rd February 2018 Uncategorised 0

Treatment with Novartis’ Ultibro Breezhaler significantly boosted lung and cardiac function in chronic obstructive pulmonary disease (COPD) patients with lung hyperinflation, trial findings show.

More: Novartis’ Ultibro Breezhaler reduces lung hyperinflation in COPD patients
Source: News